Literature DB >> 12360535

Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.

Claudia Ramaker1, Johan Marinus, Anne Margarethe Stiggelbout, Bob Johannes Van Hilten.   

Abstract

We assessed the clinometric characteristics of rating scales used for the evaluation of motor impairment and disability of patients with Parkinson's disease (PD), conducting a systematic review of PD rating scales published from 1960 to the present. Thirty studies describing clinometrics of 11 rating scales used for PD were identified. Outcome measures included validity (including factor structure), reliability (internal consistency, inter-rater, and intrarater) and responsiveness. We traced three impairment scales (Webster, Columbia University Rating Scale [CURS] and Parkinson's Disease Impairment Scale), four disability scales (Schwab and England, Northwestern University Disability Scale [NUDS], Intermediate Scale for Assessment of PD, and Extensive Disability Scale), and four scales evaluating both impairment and disability (New York University, University of California Los Angeles, Unified Parkinson's Disease Rating Scale [UPDRS], and Short Parkinson Evaluation Scale). The scales showed large differences in the extent of representation of items related to signs considered responsive to dopaminergic treatment or to those signs that appear late in the disease course and lack responsiveness to treatment. Regardless of the scale, there was a conspicuous lack of consistency concerning inter-rater reliability of bradykinesia, tremor, and rigidity. Overall disability items displayed moderate to good inter-rater reliability. The available evidence shows that CURS, NUDS, and UPDRS have moderate to good reliability and validity. In contrast to their widespread clinical use for assessment of impairment and disability in PD, the majority of the rating scales have either not been subjected to an extensive clinometric evaluation or have demonstrated clinometric shortcomings. The CURS, NUDS, and UPDRS are the most evaluated, valid, and reliable scales currently available. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12360535     DOI: 10.1002/mds.10248

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  139 in total

Review 1.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

2.  Clinical Response of Levodopa Carbidopa Combination in Patients with Idiopathic Parkinsonism.

Authors:  Abhijith Lalesh Merajoth; Pradeep Sadasivan Pillai; Thomas Iype
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Scales in Parkinson's disease.

Authors:  Georg Ebersbach; Horst Baas; Ilona Csoti; Martina Müngersdorf; Günther Deuschl
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

4.  Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.

Authors:  A Mueller; N D Abolmaali; A R Hakimi; T Gloeckler; B Herting; H Reichmann; T Hummel
Journal:  J Neural Transm (Vienna)       Date:  2005-02-15       Impact factor: 3.575

Review 5.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

6.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

7.  Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.

Authors:  Sydney E Seidel; Barbara C Tilley; Peng Huang; Yuko Y Palesch; Kenneth J Bergmann; Christopher G Goetz; Christopher J Swearingen
Journal:  Parkinsonism Relat Disord       Date:  2011-10-21       Impact factor: 4.891

Review 8.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

9.  Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Emel Zayimoğlu; Soner Çankaya
Journal:  Neurol Sci       Date:  2018-05-12       Impact factor: 3.307

10.  The Mini-BESTest is an independent predictor of falls in Parkinson Disease.

Authors:  Larissa Karlla Rodrigues Lopes; Aline Alvim Scianni; Lidiane Oliveira Lima; Raquel de Carvalho Lana; Fátima Rodrigues-De-Paula
Journal:  Braz J Phys Ther       Date:  2019-07-25       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.